Vestiage™, Inc. ("VEST"), the healthy-aging company, announced today
that they will be featured as an undiscovered Wall Street opportunity
and pick of the week on 'Under The Radar Minute,' a radio segment airing
on financial news networks on satellite radio. Uncovering emerging stock
market investment opportunities, 'Under The Radar' identifies those
companies with incredible upside potential and provides information on
those publicly traded companies before they gain the widespread
attention of Wall Street.
Airing during the open and close of the market nationally on satellite
radio to the full subscriber base, the segment says that Vestiage is
experiencing exponential growth in both its revenue verticals. On August
14th the Company announced 2nd quarter financial
results including Direct Response revenue, up 183%, overall company
revenue growth up 74% and growth margin expansion up from 49% to 69%.
The segment also opined that with the Company's growth in overall
revenue and demonstrated confidence from national retailers, Vestiage,
Inc, stock symbol VEST, is undervalued within the growth capacity matrix
and offers incredible potential as Wall Street recognition continues to
Scott Kimball, CEO of Vestiage, Inc. stated, "We're pleased to be
featured on 'Under The Radar,' and look forward to continued awareness
from investors as we grow."
More information on the upside potential of the Vestiage stock can be
found at the Under The Radar website, www.undertheradarminute.com,
or at the Company website, www.Vestiage.com.
Vestiage™ (stock symbol "VEST")
is a publicly traded healthy aging company that creates and acquires
emerging healthy aging brands. Vestiage™ brands address the top "in
demand" healthy aging concerns of men and women. The Company offers
branded science-based nutraceuticals to a strong demographic consumer
base through multiple channels. Vestiage is focused on the use of the
best ingredients from the ocean and earth, including cutting edge,
patented, clinically proven ingredients to produce highly potent, and
elegantly formulated products. Using potency and novel ingredient
combinations, Vestiage™ creates and distributes nutraceuticals such as
RegiMEN for men (www.RegimenLife.com)
and the multifunctional Monterey Bay Nutraceuticals line for women (www.MontereyBayNutra.com).
Vestiage™ research is focused on extending the active period of a human
life covering both the cognitive and physical realms. To learn more,
visit the Company website, www.vestiage.com.
As with many fast growing companies, our growth is dependent upon
adequate funding for inventory, media, general overhead, professional
fees, technology, salaries and other expenses related to the business.
Should we be unable in the future to obtain appropriate funding to pay
our expenses and media at current levels, our growth, and our financial
stability, will be negatively impacted.
This Press Release contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995 with
respect to our financial condition, results of operations and business.
These forward looking statements can be identified by the use of terms
such as "believe," "expects," "plan," "intend," "may," "will," "should,"
"can," or "anticipates," or the negative thereof, or variations thereon,
or comparable terminology, or by discussions of strategy. These
statements involve known and unknown risks, uncertainties and other
factors that may cause industry trends or our actual results to be
materially different from any future results expressed or implied by
these statements. Important factors that may cause our results to differ
from these forward-looking statements include, but are not limited to:
(i) changes in or new government regulations or increased enforcement of
the same, (ii) unavailability of desirable acquisitions or inability to
complete them, (iii) increased costs, including from increased raw
material or energy prices, (iv) changes in general worldwide economic or
political conditions, (v) adverse publicity or negative consumer
perception regarding nutritional supplements, anti-aging or stem cell
facial care products or stem cell technology in general, (vi) issues
with obtaining raw materials of adequate quality or quantity, (vii)
litigation and claims, including product liability, intellectual
property and other types, (viii) disruptions from or following
acquisitions including the loss of customers, (ix) increased
competition, (x) slow or negative growth in the anti-aging or cosmetics,
beauty, or nutritional supplement industry or the healthy foods or
anti-aging channel, (xi) the loss of key personnel or the inability to
manage our operations efficiently, (xii) problems with information
management systems, manufacturing efficiencies and operations, (xiii)
insurance coverage issues, (xiv) the volatility of the stock market
generally and of our stock specifically, (xv) increases in the cost of
borrowings or unavailability of additional debt or equity capital, or
both, or fluctuations in foreign currencies, and (xvi) interruption of
business or negative impact on sales and earnings due to acts of God,
acts of war, terrorism, bio-terrorism, civil unrest and other factors
outside of our control.
[ Back To NFVZone's Homepage ]